Essex Investment Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Essex Investment Management’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-414,982	Closed	-$992K	–	522
2019 Q3	$992K	Sell	414,982 -46,553	-10%	-$125K	0.14%	209
2019 Q2	$1.45M	Sell	461,535 -19,512	-4%	-$71.6K	0.2%	173
2019 Q1	$2.4M	Sell	481,047 -13,328	-3%	-$65.6K	0.35%	84
2018 Q4	$2.21M	Buy	494,375 +60,214	+14%	+$294K	0.35%	83
2018 Q3	$2.11M	Buy	434,161 +167,608	+63%	+$857K	0.25%	124
2018 Q2	$1.6M	Buy	266,553 +249	+0.1%	+$1.82K	0.2%	157
2018 Q1	$2.36M	Buy	+266,304	New	+$1.99M	0.31%	98

Other funds holding SBBP

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Essex Investment Management's SBBP Position: Q4 2019 in Review

Essex Investment Management sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2019, closing a stake of 414,982 shares — an estimated $992K sold.

Essex Investment Management first reported a position in SBBP in Q1 2018 and held it in 7 quarters. The position peaked at $2.4M in Q1 2019. 58 funds tracked by Wall St. Rank hold SBBP as of Q4 2019.

Essex Investment Management reported no remaining Strongbridge Biopharma plc. position as of Q4 2019 after selling out during the quarter.
Essex Investment Management sold 414,982 Strongbridge Biopharma plc. shares in Q4 2019, an estimated $992K.
Essex Investment Management first reported a position in Strongbridge Biopharma plc. in Q1 2018 and held it in 7 quarters.
Essex Investment Management's Strongbridge Biopharma plc. position peaked at $2.4M in Q1 2019.
58 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2019.

Based on Essex Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.